AbCellera Biologics Ownership | Who Owns AbCellera Biologics?

Overview Forecast RevenueFinancials Chart Transcripts

AbCellera Biologics Ownership Summary

AbCellera Biologics is owned by 35.47% institutional investors, 27.99% insiders, and 36.55% retail investors. Baker bros. advisors lp is the largest institutional shareholder, holding 9.40% of ABCL shares. American Funds SMALLCAP World A is the top mutual fund, with 2.69% of its assets in AbCellera Biologics shares.

ABCL Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	AbCellera Biologics	35.47%	27.99%	36.55%
Sector	Healthcare Stocks	88.01%	8.90%	3.09%
Industry	Biotech Stocks	109.70%	8.77%	-18.47%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Baker bros. advisors lp	27.53M	9.40%	$81.48M
Baillie gifford	21.91M	7.49%	$64.86M
Voya investment management	10.63M	3.63%	$31.47M
Ubs asset management americas	4.60M	1.57%	$13.61M
Orbimed advisors	4.18M	1.43%	$12.38M
Arrowmark colorado	4.11M	1.40%	$12.15M
Blackrock	3.80M	1.30%	$11.26M
Federated hermes	2.73M	0.93%	$8.07M
Prosight management, lp	2.35M	0.80%	$6.96M
Two sigma investments, lp	2.06M	0.70%	$6.10M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Prosight management, lp	2.35M	2.08%	$6.96M
Baker bros. advisors lp	27.53M	1.04%	$81.48M
Guardian capital advisors lp	1.79M	0.53%	$5.00M
Intellectus partners	545.53K	0.44%	$1.61M
Orbimed advisors	4.18M	0.25%	$12.38M
Novo	1.13M	0.17%	$3.34M
Jgp global gestao de recursos ltda.	22.60K	0.15%	$66.21M
Arrowmark colorado	4.11M	0.14%	$12.15M
Tang capital management	461.70K	0.14%	$1.37M
Opaleye management	200.00K	0.14%	$592.00K

Top Buyers

Holder	Shares	% Assets	Change
Ubs asset management americas	4.60M	0.00%	4.60M
Norges bank	922.21K	0.00%	922.21K
Two sigma investments, lp	2.06M	0.01%	580.44K
Prosight management, lp	2.35M	2.08%	562.63K
Tang capital management	461.70K	0.14%	461.70K

Top Sellers

Holder	Shares	% Assets	Change
Capital world investors	-	-	-5.32M
Founders fund vii management	-	-	-3.77M
Casdin capital	-	-	-2.36M
Baillie gifford	21.91M	0.05%	-1.27M
Lazard asset management	1.09M	0.00%	-927.84K

New Positions

Holder	Shares	% Assets	Change	Value
Ubs asset management americas	4.60M	0.00%	4.60M	$13.61M
Norges bank	922.21K	0.00%	922.21K	$2.73M
Tang capital management	461.70K	0.14%	461.70K	$1.37M
Citizens financial group inc/ri	311.89K	0.02%	311.89K	$923.19K
Opaleye management	200.00K	0.14%	200.00K	$592.00K

Sold Out

Holder	Change
Gamma investing	-46.00
Atticus wealth management	-100.00
Bell investment advisors	-136.00
Plante moran financial advisors	-434.00
Nverses capital	-1.10K

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Sep 30, 2024	140	-8.50%	104,569,721	-8.52%	35	2.33%	70	20.69%	34	-29.17%
Jun 30, 2024	153	-4.38%	114,320,602	-4.79%	39	2.28%	59	-21.33%	47	9.30%
Mar 31, 2024	160	5.26%	120,076,236	0.81%	41	2.45%	75	1.35%	43	13.16%
Dec 31, 2023	152	4.11%	119,116,483	0.07%	41	2.42%	74	32.14%	38	-2.56%
Sep 30, 2023	146	-16.57%	119,029,454	-4.59%	41	2.19%	56	-30.00%	39	-18.75%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
American Funds SMALLCAP World A	7.93M	2.69%	7.93M
Allianz Global Artfcl Intlgc W EUR	6.10M	2.07%	-345.00
Baillie Gifford Positive Change B Acc	4.50M	1.52%	-293.17K
UBS (Lux) Digital Health Equity SB USD	4.50M	1.52%	-
SMDS Global AI Equity Mother	4.49M	1.52%	-
Baillie Gifford Positive Change	4.49M	1.52%	-266.56K
American Funds IS® Asset Allocation 1	2.87M	0.97%	-
Baillie Gifford WW Pstv Chg B USD Acc	2.65M	0.90%	-175.76K
iShares Biotechnology ETF	1.44M	0.49%	-10.35K
Lazard Digital Health	1.04M	0.35%	60.06K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Aug 29, 2024	Thermopylae Holdings Ltd.	-	Buy	$739.98K
Nov 06, 2023	Montalbano John S.	-	Buy	$92.80K
Nov 08, 2023	Montalbano John S.	-	Buy	$44.60K
Sep 22, 2023	Hayden Michael R	-	Buy	$98.20K
Sep 12, 2023	Lecault Veronique	Chief Operating Officer	Buy	$103.80K

Insider Transactions Trends

Date	Buy	Sell
2024 Q4	-	-
2024 Q3	1	-
2024 Q2	-	-
2024 Q1	-	-
2023 Q4	2	-

ABCL Ownership FAQ

Who Owns AbCellera Biologics?

AbCellera Biologics shareholders are primarily institutional investors at 35.47%, followed by 27.99% insiders and 36.54% retail investors. The average institutional ownership in AbCellera Biologics's industry, Biotech Stocks , is 109.70%, which AbCellera Biologics falls below.

Who owns the most shares of AbCellera Biologics?

AbCellera Biologics’s largest shareholders are Baker bros. advisors lp (27.53M shares, 9.40%), Baillie gifford (21.91M shares, 7.49%), and Voya investment management (10.63M shares, 3.63%). Together, they hold 20.52% of AbCellera Biologics’s total shares outstanding.

Does Blackrock own AbCellera Biologics?

Yes, BlackRock owns 1.30% of AbCellera Biologics, totaling 3.8M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 11.26M$. In the last quarter, BlackRock decreased its holdings by -97.087K shares, a -2.49% change.

Who is AbCellera Biologics’s biggest shareholder by percentage of total assets invested?

Prosight management, lp is AbCellera Biologics’s biggest shareholder by percentage of total assets invested, with 2.08% of its assets in 2.35M AbCellera Biologics shares, valued at 6.96M$.

Who is the top mutual fund holder of AbCellera Biologics shares?

American Funds SMALLCAP World A is the top mutual fund holder of AbCellera Biologics shares, with 2.69% of its total shares outstanding invested in 7.93M AbCellera Biologics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools